4//SEC Filing
Foster Wayne 4
Accession 0000899243-22-004183
CIK 0001593899other
Filed
Feb 1, 7:00 PM ET
Accepted
Feb 2, 5:15 PM ET
Size
5.4 KB
Accession
0000899243-22-004183
Insider Transaction Report
Form 4
Foster Wayne
EVP, Chief Accounting Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-31+120,000→ 120,000 totalExercise: $7.14Exp: 2032-01-30→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]The option vests and becomes exercisable in forty-eight (48) equal monthly installments following January 31, 2022.
Documents
Issuer
Atea Pharmaceuticals, Inc.
CIK 0001593899
Entity typeother
Related Parties
1- filerCIK 0001709769
Filing Metadata
- Form type
- 4
- Filed
- Feb 1, 7:00 PM ET
- Accepted
- Feb 2, 5:15 PM ET
- Size
- 5.4 KB